These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27141953)

  • 1. Identification of Apo B48 and other novel biomarkers in amyotrophic lateral sclerosis patient fibroblasts.
    Narayan M; Seeley KW; Jinwal UK
    Biomark Med; 2016 May; 10(5):453-62. PubMed ID: 27141953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of Myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients.
    Conti A; Riva N; Pesca M; Iannaccone S; Cannistraci CV; Corbo M; Previtali SC; Quattrini A; Alessio M
    Biochim Biophys Acta; 2014 Jan; 1842(1):99-106. PubMed ID: 24184715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis.
    Oeckl P; Weydt P; Thal DR; Weishaupt JH; Ludolph AC; Otto M
    Acta Neuropathol; 2020 Jan; 139(1):119-134. PubMed ID: 31701227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteomic analysis of the cerebrospinal fluid from patients with amyotrophic lateral sclerosis based on tandem mass spectrometry technique].
    Su D; Zhang Y; Bi F; Xiao B
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Apr; 39(4):428-436. PubMed ID: 31068286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis.
    Mitropoulos K; Katsila T; Patrinos GP; Pampalakis G
    OMICS; 2018 Jan; 22(1):52-64. PubMed ID: 29356625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects.
    Xu Z; Lee A; Nouwens A; Henderson RD; McCombe PA
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):362-376. PubMed ID: 29384411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis.
    Pampalakis G; Mitropoulos K; Xiromerisiou G; Dardiotis E; Deretzi G; Anagnostouli M; Katsila T; Rentzos M; Patrinos GP
    Hum Mutat; 2019 Apr; 40(4):361-373. PubMed ID: 30556231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis.
    Leoni E; Bremang M; Mitra V; Zubiri I; Jung S; Lu CH; Adiutori R; Lombardi V; Russell C; Koncarevic S; Ward M; Pike I; Malaspina A
    Sci Rep; 2019 Mar; 9(1):4478. PubMed ID: 30872628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
    Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary electrophoresis tandem mass spectrometry determination of glutamic acid and homocysteine's metabolites: Potential biomarkers of amyotrophic lateral sclerosis.
    Cieslarova Z; Lopes FS; do Lago CL; França MC; Colnaghi Simionato AV
    Talanta; 2017 Aug; 170():63-68. PubMed ID: 28501214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for amyotrophic lateral sclerosis.
    Bowser R; Cudkowicz M; Kaddurah-Daouk R
    Expert Rev Mol Diagn; 2006 May; 6(3):387-98. PubMed ID: 16706741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroproteomics: an insight into ALS.
    Mendonça DM; Pizzati L; Mostacada K; de S Martins SC; Higashi R; Ayres Sá L; Moura Neto V; Chimelli L; Martinez AM
    Neurol Res; 2012 Dec; 34(10):937-43. PubMed ID: 23146297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H; Bowser R
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in muscle proteome of patients diagnosed with amyotrophic lateral sclerosis.
    Elf K; Shevchenko G; Nygren I; Larsson L; Bergquist J; Askmark H; Artemenko K
    J Proteomics; 2014 Aug; 108():55-64. PubMed ID: 24846852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
    Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
    BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients.
    Allen SP; Duffy LM; Shaw PJ; Grierson AJ
    Neurobiol Aging; 2015 Oct; 36(10):2893-903. PubMed ID: 26344876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model Studies.
    Brancia C; Noli B; Boido M; Boi A; Puddu R; Borghero G; Marrosu F; Bongioanni P; Orrù S; Manconi B; D'Amato F; Messana I; Vincenzoni F; Vercelli A; Ferri GL; Cocco C
    PLoS One; 2016; 11(10):e0164689. PubMed ID: 27737014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.
    Gonçalves M; Tillack L; de Carvalho M; Pinto S; Conradt HS; Costa J
    Clin Chim Acta; 2015 Jan; 438():342-9. PubMed ID: 25261856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.